PLX: Protalix BioTherapeutics Inc. (DE) Stocks News on November 9, 2025

Protalix BioTherapeutics to Announce Third Quarter 2025 Financial and Business Results on November 13, 2025

PLX

PR Newswire

3 days ago

Protalix BioTherapeutics to Announce Third Quarter 2025 Financial and Business Results on November 13, 2025

Chiesi Global Rare Diseases and Protalix BioTherapeutics Seek Re-examination from the EMA for the Negative Opinion for Elfabrio (pegunigalsidase alfa) Alternative Dosing Regimen of Every Four Weeks in the EU

PLX

GlobeNewswire

6 days ago

Chiesi Global Rare Diseases and Protalix BioTherapeutics Seek Re-examination from the EMA for the Negative Opinion for Elfabrio (pegunigalsidase alfa) Alternative Dosing Regimen of Every Four Weeks in the EU

Can Protalix (PLX) Turn Regulatory Setbacks Into a Competitive Advantage in Rare Disease Markets?

PLX

Simply Wall St.

21 days ago

Can Protalix (PLX) Turn Regulatory Setbacks Into a Competitive Advantage in Rare Disease Markets?

Protalix BioTherapeutics (PLX): Evaluating Valuation After EMA Setback on Elfabrio Dosing Regimen

PLX

Simply Wall St.

22 days ago

Protalix BioTherapeutics (PLX): Evaluating Valuation After EMA Setback on Elfabrio Dosing Regimen

Chiesi Global Rare Diseases and Protalix Biotherapeutics Acknowledge CHMP Negative Opinion on Every Four Week Dosing Regimen of Elfabrio® (pegunigalsidase alfa) in the EU

PLX

GlobeNewswire

23 days ago

Chiesi Global Rare Diseases and Protalix Biotherapeutics Acknowledge CHMP Negative Opinion on Every Four Week Dosing Regimen of Elfabrio® (pegunigalsidase alfa) in the EU

Fabry Disease Treatment Analysis Report 2025 | Market to Reach $3.86 Billion by 2030, Rising Fabry Disease Prevalence and Demand for Targeted Therapies Drive Growth

PLX

GlobeNewswire

4 months ago

Fabry Disease Treatment Analysis Report 2025 | Market to Reach $3.86 Billion by 2030, Rising Fabry Disease Prevalence and Demand for Targeted Therapies Drive Growth

Protalix BioTherapeutics to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC

PLX

PR Newswire

6 months ago

Protalix BioTherapeutics to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC

PLX

Zacks Small Cap Research

6 months ago

PLX: First Quarter Results

Protalix BioTherapeutics Inc (PLX) Q1 2025 Earnings Call Highlights: Revenue Surge and ...

PLX

GuruFocus.com

6 months ago

Protalix BioTherapeutics Inc (PLX) Q1 2025 Earnings Call Highlights: Revenue Surge and ...

PLX

Associated Press Finance

6 months ago

Protalix: Q1 Earnings Snapshot

Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business Results

PLX

PR Newswire

6 months ago

Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business Results

Protalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, 2025

PLX

PR Newswire

6 months ago

Protalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, 2025

PLX

Simply Wall St.

7 months ago

Top Penny Stocks To Watch In April 2025

Protalix BioTherapeutics And 2 Other Promising Penny Stocks

PLX

Simply Wall St.

7 months ago

Protalix BioTherapeutics And 2 Other Promising Penny Stocks

Protalix BioTherapeutics to Present at the iAccess Alpha Virtual Best Ideas Spring Conference 2025

PLX

PR Newswire

8 months ago

Protalix BioTherapeutics to Present at the iAccess Alpha Virtual Best Ideas Spring Conference 2025

Is Protalix BioTherapeutics (PLX) The High Growth Low Debt Stock to Invest in Now?

PLX

Insider Monkey

8 months ago

Is Protalix BioTherapeutics (PLX) The High Growth Low Debt Stock to Invest in Now?

iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025

PLX

ACCESS Newswire

8 months ago

iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025

PLX

Zacks Small Cap Research

8 months ago

PLX: 2024 Results

Protalix BioTherapeutics Inc (PLX) Q4 2024 Earnings Call Highlights: Record Revenue Growth ...

PLX

GuruFocus.com

8 months ago

Protalix BioTherapeutics Inc (PLX) Q4 2024 Earnings Call Highlights: Record Revenue Growth ...

Protalix BioTherapeutics Reports Fiscal Year 2024 Financial and Business Results

PLX

PR Newswire

8 months ago

Protalix BioTherapeutics Reports Fiscal Year 2024 Financial and Business Results

Protalix BioTherapeutics to Announce Fiscal Year 2024 Financial and Business Results on March 17, 2025

PLX

PR Newswire

8 months ago

Protalix BioTherapeutics to Announce Fiscal Year 2024 Financial and Business Results on March 17, 2025

3 US Penny Stocks With Market Caps Under $400M To Watch

PLX

Simply Wall St.

9 months ago

3 US Penny Stocks With Market Caps Under $400M To Watch

Protalix BioTherapeutics to Participate in the 2025 BIO CEO & Investor Conference

PLX

PR Newswire

9 months ago

Protalix BioTherapeutics to Participate in the 2025 BIO CEO & Investor Conference

PLX

Zacks Small Cap Research

9 months ago

PLX: Revisiting the Thesis

US Penny Stocks: Arbe Robotics And 2 More Promising Picks

PLX

Simply Wall St.

10 months ago

US Penny Stocks: Arbe Robotics And 2 More Promising Picks

Protalix BioTherapeutics Issues 2025 Letter to Stockholders

PLX

PR Newswire

a year ago

Protalix BioTherapeutics Issues 2025 Letter to Stockholders

EMA validates Chiesi and Protalix’s dose variation for Fabry disease

PLX

Pharmaceutical Technology

a year ago

EMA validates Chiesi and Protalix’s dose variation for Fabry disease

Promising US Penny Stocks To Watch In December 2024

PLX

Simply Wall St.

a year ago

Promising US Penny Stocks To Watch In December 2024

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Validation of Variation Submission by European Medicines Agency for pegunigalsidase alfa

PLX

PR Newswire

a year ago

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Validation of Variation Submission by European Medicines Agency for pegunigalsidase alfa

PLX: Self-Sustaining Rise to Lead in Renal Rare Disease

PLX

Zacks Small Cap Research

a year ago

PLX: Self-Sustaining Rise to Lead in Renal Rare Disease

Protalix BioTherapeutics Inc (PLX) Q3 2024 Earnings Call Highlights: Revenue Surge and ...

PLX

GuruFocus.com

a year ago

Protalix BioTherapeutics Inc (PLX) Q3 2024 Earnings Call Highlights: Revenue Surge and ...

PLX

Associated Press Finance

a year ago

Protalix: Q3 Earnings Snapshot

Protalix BioTherapeutics Reports Third Quarter 2024 Financial and Business Results

PLX

PR Newswire

a year ago

Protalix BioTherapeutics Reports Third Quarter 2024 Financial and Business Results

Protalix BioTherapeutics to Announce Third Quarter 2024 Financial and Business Results on November 14, 2024

PLX

PR Newswire

a year ago

Protalix BioTherapeutics to Announce Third Quarter 2024 Financial and Business Results on November 14, 2024

Accolade And 2 Other Penny Stocks To Watch On US Exchanges

PLX

Simply Wall St.

a year ago

Accolade And 2 Other Penny Stocks To Watch On US Exchanges

Protalix BioTherapeutics to Present Phase I PRX-115 Data in Late-Breaking Poster at ACR Convergence 2024

PLX

PR Newswire

a year ago

Protalix BioTherapeutics to Present Phase I PRX-115 Data in Late-Breaking Poster at ACR Convergence 2024

PLX

Zacks Small Cap Research

a year ago

OTC Markets Hosts Virtual Investor Presentation with Dror Bashan, President & CEO of Protalix Biotherapeutics, and John Vandermosten, Senior Analyst at Zacks SCR

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

PLX

GlobeNewswire

a year ago

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

Life Sciences Virtual Investor Forum Agenda Announced for September 19th

PLX

GlobeNewswire

a year ago

Life Sciences Virtual Investor Forum Agenda Announced for September 19th

Protalix BioTherapeutics to Present at the Life Sciences Investor Forum September 19, 2024

PLX

GlobeNewswire

a year ago

Protalix BioTherapeutics to Present at the Life Sciences Investor Forum September 19, 2024

Protalix BioTherapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

PLX

PR Newswire

a year ago

Protalix BioTherapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Protalix BioTherapeutics Announces Repayment of Outstanding Senior Secured Convertible Promissory Notes

PLX

PR Newswire

a year ago

Protalix BioTherapeutics Announces Repayment of Outstanding Senior Secured Convertible Promissory Notes

Is Protalix BioTherapeutics, Inc. (PLX) The Best Rated Penny Stock To Buy According to Analysts?

PLX

Insider Monkey

a year ago

Is Protalix BioTherapeutics, Inc. (PLX) The Best Rated Penny Stock To Buy According to Analysts?

PLX

Zacks Small Cap Research

a year ago

PLX: A Focus on Renal Rare Disease

PLX

Associated Press Finance

a year ago

Protalix: Q2 Earnings Snapshot

Protalix BioTherapeutics Reports Second Quarter 2024 Financial and Business Results

PLX

PR Newswire

a year ago

Protalix BioTherapeutics Reports Second Quarter 2024 Financial and Business Results

Protalix BioTherapeutics to Announce Second Quarter 2024 Financial and Business Results on August 14, 2024

PLX

PR Newswire

a year ago

Protalix BioTherapeutics to Announce Second Quarter 2024 Financial and Business Results on August 14, 2024

Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled Gout

PLX

PR Newswire

a year ago

Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled Gout

Lotto 6/49 - $64 million up for grabs in the next draw!

PLX

CNW Group

a year ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

PLX

Simply Wall St.

a year ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

PLX

AFP

a year ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

PLX

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

PLX

Simply Wall St.

a year ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

PLX

Barrons.com

a year ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

PLX

Simply Wall St.

a year ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

PLX

Simply Wall St.

a year ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Protalix BioTherapeutics to Present at the 2024 BIO International Convention

PLX

PR Newswire

a year ago

Protalix BioTherapeutics to Present at the 2024 BIO International Convention

PLX

Zacks Small Cap Research

a year ago

PLX: First Quarter Update

PLX

GuruFocus.com

a year ago

Protalix BioTherapeutics Inc (PLX) Q1 2024 Earnings Call Transcript Highlights: Navigating ...

Protalix BioTherapeutics, Inc. (AMEX:PLX) Q1 2024 Earnings Call Transcript

PLX

Insider Monkey

a year ago

Protalix BioTherapeutics, Inc. (AMEX:PLX) Q1 2024 Earnings Call Transcript

PLX

Associated Press Finance

a year ago

Protalix: Q1 Earnings Snapshot

Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business Results

PLX

PR Newswire

a year ago

Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business Results

Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024

PLX

PR Newswire

2 years ago

Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024

Protalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call Transcript

PLX

Insider Monkey

2 years ago

Protalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call Transcript

PLX

Zacks Small Cap Research

2 years ago

PLX: Elfabrio Geographic Expansion

PLX

GuruFocus.com

2 years ago

Protalix BioTherapeutics Inc Reports Revenue Growth and Net Income Gain in FY 2023

Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results

PLX

PR Newswire

2 years ago

Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results

Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024

PLX

PR Newswire

2 years ago

Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024

Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference

PLX

PR Newswire

2 years ago

Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference

Silvercorp Reports High-Grade Silver Drill Results at The TLP Mine

PLX

PR Newswire

2 years ago

Silvercorp Reports High-Grade Silver Drill Results at The TLP Mine

PLX

Argus Research

2 years ago

Daily – Vickers Top Insider Picks for 01/29/2024

Syros (SYRS) Stock Surges 200% in 3 Months: Here's Why

PLX

Zacks

2 years ago

Syros (SYRS) Stock Surges 200% in 3 Months: Here's Why

Perspective Therapeutics Announces Pricing of $60.0 Million Public Offering And $20.8 Million Private Placement

PLX

GlobeNewswire

2 years ago

Perspective Therapeutics Announces Pricing of $60.0 Million Public Offering And $20.8 Million Private Placement

5 Small-Cap Stocks to Play the January Effect

PLX

Zacks

2 years ago

5 Small-Cap Stocks to Play the January Effect

Aviat Networks to Participate in Upcoming Investor Conferences

PLX

PR Newswire

2 years ago

Aviat Networks to Participate in Upcoming Investor Conferences

PLX

GlobeNewswire

2 years ago

Guggenheim Investments Announces January 2024 Closed-End Fund Distributions

PLX

Zacks

2 years ago

The Zacks Analyst Blog Highlights Allogene Therapeutics, Arcutis Biotherapeutics and C4 Therapeutics

Protalix BioTherapeutics Issues 2024 Letter to Stockholders

PLX

PR Newswire

2 years ago

Protalix BioTherapeutics Issues 2024 Letter to Stockholders

Seismic Industry Veteran Stephen Jumper Joins Geospace Technologies Board of Directors

PLX

Business Wire

2 years ago

Seismic Industry Veteran Stephen Jumper Joins Geospace Technologies Board of Directors

Annexon Outlines Global Registrational Program for ANX007 in Geographic Atrophy with FDA Alignment on Vision Preservation as Primary Endpoint

PLX

GlobeNewswire

2 years ago

Annexon Outlines Global Registrational Program for ANX007 in Geographic Atrophy with FDA Alignment on Vision Preservation as Primary Endpoint

C&F Financial Corporation Reauthorizes Share Repurchase Program

PLX

GlobeNewswire

2 years ago

C&F Financial Corporation Reauthorizes Share Repurchase Program

Charif Souki, Godfather of American LNG Industry, Is Ousted from Tellurian

PLX

The Wall Street Journal

2 years ago

Charif Souki, Godfather of American LNG Industry, Is Ousted from Tellurian

Knowles Corporation's (NYSE:KN) P/S Is On The Mark

PLX

Simply Wall St.

2 years ago

Knowles Corporation's (NYSE:KN) P/S Is On The Mark

Smith & Wesson Brands, Inc. (NASDAQ:SWBI) is largely controlled by institutional shareholders who own 52% of the company

PLX

Simply Wall St.

2 years ago

Smith & Wesson Brands, Inc. (NASDAQ:SWBI) is largely controlled by institutional shareholders who own 52% of the company

Insider Sell Alert: CEO Raymond Pittman Unloads 273,720 Shares of Matterport Inc (MTTR)

PLX

GuruFocus.com

2 years ago

Insider Sell Alert: CEO Raymond Pittman Unloads 273,720 Shares of Matterport Inc (MTTR)

Renesas Extends Tender Offer and Receives Taiwan Merger Control Approval for Proposed Acquisition of Sequans

PLX

Newsfile

2 years ago

Renesas Extends Tender Offer and Receives Taiwan Merger Control Approval for Proposed Acquisition of Sequans

With 61% ownership of the shares, Gilat Satellite Networks Ltd. (NASDAQ:GILT) is heavily dominated by institutional owners

PLX

Simply Wall St.

2 years ago

With 61% ownership of the shares, Gilat Satellite Networks Ltd. (NASDAQ:GILT) is heavily dominated by institutional owners

PLX

GlobeNewswire

2 years ago

Guggenheim Investments Announces December 2023 Closed-End Fund Distributions

PLX

GlobeNewswire

2 years ago

Levicept Appoints Eliot Forster as CEO

Insider Sell: EVP, CFO Kristopher Westbrooks Sells Shares of TimkenSteel Corp (TMST)

PLX

GuruFocus.com

2 years ago

Insider Sell: EVP, CFO Kristopher Westbrooks Sells Shares of TimkenSteel Corp (TMST)

Insider Sell: CFO William Burns Sells 15,000 Shares of Cross Country Healthcare Inc (CCRN)

PLX

GuruFocus.com

2 years ago

Insider Sell: CFO William Burns Sells 15,000 Shares of Cross Country Healthcare Inc (CCRN)

PLX

Motley Fool

2 years ago

2 of the Cheapest Stocks I Own

DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers

PLX

GlobeNewswire

2 years ago

DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers

Protalix BioTherapeutics, Inc. (AMEX:PLX) Q3 2023 Earnings Call Transcript

PLX

Insider Monkey

2 years ago

Protalix BioTherapeutics, Inc. (AMEX:PLX) Q3 2023 Earnings Call Transcript

PLX

Zacks Small Cap Research

2 years ago

PLX: More Regulatory Approvals

PLX

GlobeNewswire

2 years ago

Latest Protalix BioTherapeutics Inc. (DE) (PLX) News on November 9, 2025

Share on Social Networks: